Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Cartesian Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| | Security Type | | | Security Class Title | | | Fee Calculation Rule | | | Amount Registered | | | Proposed Maximum Offering Price Per Share | | | Maximum Aggregate Offering Price | | | Fee Rate | | | Amount of Registration Fee | |
Fees to Be Paid | | Equity | | | Common stock, par value $0.0001 per share(1) | | | Rule 457(c) | | | | 11,392,350(2 | ) | | $ | 20.89(3 | )
| | $ | 237,986,191.50(3 | )
| | | 0.0001531 | | | $ | 36,435.69 |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Fees Previously Paid | | N/A | | | N/A | | | N/A | | | | N/A | | | | N/A | | | | N/A | | | | N/A | | | | N/A | |
| | | | | | | | | | | | | | | | | | | |
| | Total Offering Amounts | | | | | | | $ | 237,986,191.50 |
| | | | | | $ | 36,435.69 |
|
| | | | | | | | | | | | | | | | | | | |
| | Total Fees Previously Paid | | | | | | | | | | | | | | | | — | |
| | | | | | | | | | | | | | | | | | | |
| | Total Fee Offsets | | | | | | | | | | | | | | | | — | |
| | | | | | | | | | | | | | | | | | | |
| | Net Fee Due | | | | | | | | | | | | | | | $ | 36,435.69 |
|
(1) | Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers such an indeterminate amount of shares of common stock, par value $0.0001 per share (“Common Stock”), as may become issuable to prevent dilution resulting from stock splits, stock dividends and similar events. |
(2) | The amount registered consists of up to (i) 9,512,275 shares of Common Stock, (ii) 1,880,075 shares of Common Stock issuable upon the conversion of 56,402.254 shares of Series A Non-Voting Convertible Preferred Stock, par value $0.0001 per share (“Series A Preferred Stock”). |
(3) | Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the shares of Common Stock on the Nasdaq Global Market on December 12, 2024 (such date being within five business days of the date that this registration statement was first filed with the Securities and Exchange Commission, in accordance with Rule 457(c) under the Securities Act). |